Frequency and Risk factors of Reoperation in LDLT Donors
DOI:
https://doi.org/10.37978/tijfs.v7i1.421Keywords:
Re-exploration, Postoperative complications, Gender disparity, Operation timeAbstract
Background:
Liver transplantation (LT) is the definitive treatment for end-stage liver disease, acute liver failure, liver tumors, and metabolic diseases. Re-exploration after surgery is associated with poor clinical outcomes and is considered a quality-of-care measure.
Objective:
To determine the frequency and risk factors of reoperation (early re-laparotomy) after hepatectomy in postoperative LDLT donors.
Materials and Methods:
A cross-sectional analytical study was conducted at the Pir Abdul Qadir Shah Jeelani Institute of Medical Sciences between December 2023 and May 2024. This study included 672 LDLT donors aged > 18 years old. Data on donor age, sex, blood group, operation time, and re-exploration were collected. The primary endpoints were the frequency and causes of re-exploration, and the secondary endpoints included the association of re-exploration with clinical outcomes. Statistical analyses were performed using SPSS 25.0, with the significance level set at P < 0.05.
Blood group analysis revealed that 57.9% of reexplored donors had blood group B+.
Results:
The frequency of re-exploration was 2.8%. Among those requiring re-exploration, 42.1% were aged 21-28 years. The difference in re-exploration rates between male and female patients was statistically significant (P<0.001). Blood group analysis revealed that 57.9% of the reexplored donors had blood group B+. Bleeding was the primary cause of re-exploration in 73.7% of cases. The majority (57.9%) of re-explorations occurred in patients with operation times between 451-550 minutes.
However, the significant sex disparity and high incidence of bleeding as a cause for re-exploration underscores the need for improved postoperative care.
Conclusion:
This study highlights a relatively low frequency of re-exploration (2.8%) among LDLT donors. However, the significant sex disparity and high incidence of bleeding as a cause for re-exploration underscore the need for improved postoperative care.
References
Ohe H, Hoshino J, Ozawa M. Factors affecting outcomes of liver transplantation: an analysis of OPTN/UNOS database. Clin Transpl. 2011:39-53.
Nydam TL, Reddy MS, Pomfret EA, Rela M. Progression of living liver donation worldwide. Curr Opin Organ Transplant. 2018;23(2):162-8. DOI: https://doi.org/10.1097/MOT.0000000000000516
Kawasaki S, Makuuchi M, Matsunami H, Hashikura Y, Ikegami T, Nakazawa Y, et al. Living related liver transplantation in adults. Ann Surg. 1998;227(2):269-74. DOI: https://doi.org/10.1097/00000658-199802000-00017
Shah SA, Levy GA, Greig PD, Smith R, McGilvray ID, Lilly LB, et al. Reduced mortality with right-lobe living donor compared to deceased-donor liver transplantation when analyzed from the time of listing. Am J Transplant. 2007;7(4):998-1002. DOI: https://doi.org/10.1111/j.1600-6143.2006.01692.x
Beavers KL, Sandler RS, Shrestha R. Donor morbidity associated with right lobectomy for living donor liver transplantation to adult recipients: a systematic review. Liver Transpl. 2002;8(2):110-7. DOI: https://doi.org/10.1053/jlts.2002.31315
Birkmeyer JD, Hamby LS, Birkmeyer CM, Decker MV, Karon NM, Dow RW. Is unplanned return to the operating room a useful quality indicator in general surgery? Arch Surg. 2001;136(4):405-11. DOI: https://doi.org/10.1001/archsurg.136.4.405
Kroon HM, Breslau PJ, Lardenoye JW. Can the incidence of unplanned reoperations be used as an indicator of quality of care in surgery? Am J Med Qual. 2007;22(3):198-202. DOI: https://doi.org/10.1177/1062860607300652
Kawaguchi Y, Sugawara Y, Akamatsu N, Kaneko J, Hamada T, Tanaka T, et al. Impact of early reoperation following living-donor liver transplantation on graft survival. PLoS One. 2014;9(11):e109731.
Hendriks HG, van der Meer J, de Wolf JT, Peeters PM, Porte RJ, de Jong K, et al. Intraoperative blood transfusion requirement is the main determinant of early surgical re-intervention after orthotopic liver transplantation. Transpl Int. 2005;17(11):673-9.
Freise CE, Gillespie BW, Koffron AJ, Lok AS, Pruett TL, Emond JC, et al. Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study. Am J Transplant. 2008;8(12):2569-79.
Freise CE, Gillespie BW, Koffron AJ, Lok AS, Pruett TL, Emond JC, et al.; for A2ALL Study Group. Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study. Am J Transplant 2008;8:2569-2579. DOI: https://doi.org/10.1111/j.1600-6143.2008.02440.x
Li C, Mi K, Wen TF, Yan LN, Li B, Yang JY, et al. Outcomes of patients with benign liver diseases undergoing living donor versus deceased donor liver transplantation. PLoS One 2011;6: e27366. DOI: https://doi.org/10.1371/journal.pone.0027366
Yoshiya S, Shirabe K, Kimura K, Yoshizumi T, Ikegami T, Kayashima H, et al. The causes, risk factors, and outcomes of early re-laparotomy after living-donor liver transplantation. Transplantation 2012;94:947-952. DOI: https://doi.org/10.1097/TP.0b013e31826969e6
Kawaguchi Y, Sugawara Y, Akamatsu N, Kaneko J, Hamada T, Tanaka T, et al. Impact of early reoperation following living donor liver transplantation on graft survival. PLoS One 2014;9:e109731. DOI: https://doi.org/10.1371/journal.pone.0109731
Hendriks HG, van der Meer J, de Wolf JT, Peeters PM, Porte RJ, de Jong K, et al. Intraoperative blood transfusion requirement is the main determinant of early surgical re-intervention after orthotopic liver transplantation. Transpl Int 2005;17:673-679. DOI: https://doi.org/10.1007/s00147-004-0793-5
Chen H, Chen H, Liang K. Postoperative bleeding after liver transplantation: a single-center retrospective analysis. Transplant Proc. 2020;52(10):3181-3186.
Northup PG, Caldwell SH. Coagulation in liver disease: a guide for the clinician. Clin Gastroenterol Hepatol. 2013;11(9):1064-1074. DOI: https://doi.org/10.1016/j.cgh.2013.02.026
Schwartz M, D'Amico F, Vitale A. Management of bleeding complications in liver transplantation. Surg Clin North Am. 2015;95(2):373-384.
Weiss MJ, Fair JH, Uemura T, et al. Impact of bleeding complications following liver transplantation. Hepatobiliary Surg Nutr. 2015;4(2):145-153.
Adam R, Karam V, Cailliez V, O'Grady J. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl. 2018;24(9):1215-1225. DOI: https://doi.org/10.1002/lt.25208
Lisman T, Porte RJ. Pathogenesis, prevention, and management of bleeding and thrombosis in patients with liver disease. Best Pract Res Clin Gastroenterol. 2014;28(6):946-957.
Burra P, De Bona M, Germani G, et al. Educational needs in liver transplantation: the patient's perspective. Liver Transpl. 2011;17(7):777-784.
Kwong AJ, Kim WR, Lake JR, Smith JM, Schladt DP, Skeans MA, et al. OPTN/SRTR 2018 Annual Data Report: Liver. Am J Transplant. 2020;20 Suppl s1:193-299. DOI: https://doi.org/10.1111/ajt.15674
Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736-1788. DOI: https://doi.org/10.1016/S0140-6736(18)32203-7
Kalaitzakis E, Kamis G, Skagen C, et al. Metabolic syndrome and post-liver transplant de novo malignancy: an emerging problem? Hepatology. 2014;60(4):1444-1451.
Burra P, De Bona M, Germani G, et al. Educational needs in liver transplantation: the patient's perspective. Liver Transpl. 2011;17(7):777-784 DOI: https://doi.org/10.1002/lt.22294
Downloads
Published
Issue
Section
License
Copyright (c) 2024 The International Journal of Frontier Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
